Compare Lloyds Banking Group Plc American Depositary Shares (LYG) vs Royalty Pharma plc Class A Ordinary Shares (RPRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Lloyds Banking Group Plc American Depositary Shares vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? Lloyds Banking Group Plc American Depositary Shares trades at $5.4 (market cap $76.34B), while Royalty Pharma plc Class A Ordinary Shares trades at $57.01 (market cap $25.27B). The key difference: Lloyds Banking Group Plc American Depositary Shares is far larger — about 3× Royalty Pharma plc Class A Ordinary Shares's market cap, and Lloyds Banking Group Plc American Depositary Shares pays the higher dividend (4.05%). Which is the better fit depends on your goals — on Pluang, investors hold Lloyds Banking Group Plc American Depositary Shares for 1 Days and Royalty Pharma plc Class A Ordinary Shares for 0 Days on average.
| LYG | RPRX | |
|---|---|---|
Market Cap | $76.34B | $25.27B |
Volume | 16,671,733 | 3,671,183 |
Sector | Financials | Health |
52-Week High | $6.28 | $63.96 |
52-Week Low | $4.42 | $35.44 |
Typical Hold Time | 1 Days | 0 Days |
Enterprise Value | $99.66B | $32.50B |
Dividend Yield | 4.05% | 1.66% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Lloyds Banking Group Plc American Depositary Shares
Lloyds Banking Group provides retail, commercial, and insurance services in the United Kingdom. Its banking brands include Lloyds Bank, Halifax, and Bank of Scotland.
Read more on LYG →About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →
